Samsung Biologics
Incheon, KR
Program data pending ClinicalTrials.gov matching
· Last scored 2026-04-02
67.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (20)
○ EMA GMP
○ MHRA GMP
Quick Facts: Samsung Biologics
- Signal Score
- 67.0/100 (as of 2026-04-02)
- Quality Compliance
- Assessment pending
- Headquarters
- Incheon, KR
- Modalities
- Cell Therapy, mRNA
- Active Programs
- No ClinicalTrials.gov matches confirmed — 1 partnership announcement in press
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer. 1 partnership announcement found in press monitoring.
Programs
— no verified data
Sponsors— no verified data
ModalitiesCell Therapy, mRNA
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Partnership Announcements (from press monitoring)
Financial Stability
60.0
M&A activity detected (5 articles)
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
M&A activity detected (5 articles)
Capacity
74.0
Active facility expansion (6 articles)
Strong partnership activity (14 articles)
Regulatory milestones (4 articles)
Sites: Incheon, KR
Source: SEC EDGAR, press monitoring, company profiles
1 manufacturing site
Recent Press20 articles
Active facility expansion (6 articles)
Strong partnership activity (14 articles)
Regulatory milestones (4 articles)
Recent News 20 articles
Governor Moore celebrates opening of Samsung Biologics' first U.S. manufacturing facility in Maryland - nottinghammd.com
Governor Moore celebrates opening of Samsung Biologics' first U.S. manufacturing facility in Maryland nottinghammd.com
Samsung Biologics secures first manufacturing base in U.S. - 매일경제
Samsung Biologics secures first manufacturing base in U.S. 매일경제
Samsung Biologics Seeks Injunction to Block Union’s First Strike - Businesskorea
Samsung Biologics Seeks Injunction to Block Union’s First Strike Businesskorea
Samsung Biologics Launches New U.S. Facility in Maryland - BioBuzz
Samsung Biologics Launches New U.S. Facility in Maryland news.biobuzz.io
Samsung Biologics completes Maryland acquisition, establishes first U.S. manufacturing site - The Manufacturer
Samsung Biologics completes Maryland acquisition, establishes first U.S. manufacturing site The Manufacturer
Samsung Biologics Acquires GSK’s Manufacturing Facility in Maryland, US - CHEManager
Samsung Biologics Acquires GSK’s Manufacturing Facility in Maryland, US CHEManager
Samsung Biologics acquires GSK’s facility in Maryland, US - Investment Monitor
Samsung Biologics acquires GSK’s facility in Maryland, US Investment Monitor
Samsung Biologics completes $353 mln Maryland, US plant acquisition - ajupress.com
Samsung Biologics completes $353 mln Maryland, US plant acquisition aju press
Samsung Biologics completes GSK US plant deal - The Korea Herald
Samsung Biologics completes GSK US plant deal The Korea Herald
Samsung Biologics completes acquisition of US manufacturing facility - The Korea Times
Samsung Biologics completes acquisition of US manufacturing facility The Korea Times
Samsung Biologics finalizes acquisition of GSK's Maryland plant - Korea JoongAng Daily
Samsung Biologics finalizes acquisition of GSK's Maryland plant Korea JoongAng Daily
Samsung Biologics Union Votes in Favor of Strike - Supply Chain Brain
Samsung Biologics Union Votes in Favor of Strike Supply Chain Brain
Samsung Biologics Acquires 60,000-Liter U.S. Facility - 조선일보
Samsung Biologics Acquires 60,000-Liter U.S. Facility 조선일보
Samsung Biologics completes acquisition of GSK's manufacturing facility in Rockville, Maryland - BioSpace
Samsung Biologics completes acquisition of GSK's manufacturing facility in Rockville, Maryland BioSpace
Samsung Biologics opens facility in Montgomery County - Maryland Daily Record
Samsung Biologics opens facility in Montgomery County thedailyrecord.com
Samsung Biologics: U.S. Expansion With Acquisition Of GSK Manufacturing Facility In Maryland - pulse2.com
Samsung Biologics: U.S. Expansion With Acquisition Of GSK Manufacturing Facility In Maryland Pulse 2.0
Samsung Biologics wins CDMO Leadership Awards, highlighting sustainability efforts - 더바이오
Samsung Biologics wins CDMO Leadership Awards, highlighting sustainability efforts 더바이오
Samsung Biologics opens first U.S. manufacturing site in Maryland - WUSA9
Samsung Biologics opens first U.S. manufacturing site in Maryland WUSA9
Samsung Biologics completes acquisition of GSK's manufacturing facility in Rockville, Maryland - Yahoo Finance
Samsung Biologics completes acquisition of GSK's manufacturing facility in Rockville, Maryland Yahoo Finance
Samsung Biologics completes GSK facility acquisition in Maryland By Investing.com - Investing.com India
Samsung Biologics completes GSK facility acquisition in Maryland By Investing.com Investing.com India
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Merck KGaA / MilliporeSigma (CDMO)
Darmstadt, DE · St. Louis, MO
Signal Score: 81.8
mRNA, Biologics, Cell Therapy
Danaher (CGT Portfolio)
Washington, DC
Signal Score: 81.5
Cell Therapy, AAV, mRNA
Lonza
Basel, Switzerland
Signal Score: 78.6
AAV, Lentiviral, Cell Therapy, mRNA
CCRM
Toronto, ON, Canada
Signal Score: 78.1
Cell Therapy, mRNA
Cytiva (Mfg Services)
Marlborough, MA · Uppsala, SE
Signal Score: 74.0
Cell Therapy, AAV, mRNA